PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Clinical trial NCT06665100 · RECRUITING

Trial details

NCT number: NCT06665100
Sponsor: Pulmotect, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies Hematopoietic Stem Cell Transplant (HSCT)

Start date: 2025-06-27
Primary completion: 2027-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.